4.5 Interaction with other medicinal products and other forms of interaction   
 No formal drug interaction studies have been conducted with LEMTRADA using the recommended dose in patie nts with MS. In a controlled clinical trial in MS patients recently treated with beta interferon and glatiramer acetate were required to discontinue treatment 28  days before initiating treatment with LEMTRADA . 
 
